Skip to main content
. 2019 Apr;22(4):384–390. doi: 10.22038/ijbms.2019.31788.7651

Figure 4.

Figure 4

Effects of empagliflozin on renal caspase-3 levels (A to B). A and B: as assessed by Immunofluorescence analysis; and obtained data were normalized by the values of the control group. C and D: as assayed by Western blotting; the values were first normalized by β-actin intensities and then were reported related to the values of the control group. Control, healthy control rats; Diab, diabetic control rats; EMP, diabetic rats treated with empagliflozin. ***P<0.01 vs Control group. ©©©P<0.01 vs Diab rats